View in EDS HTML Full Text PDF Full Text

Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?

Saved in:
Bibliographic Details
Title: Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?
Authors: Panda, Prateek Kumar (AUTHOR), Sharawat, Indar Kumar (AUTHOR)
Source: Acta Neurologica Scandinavica. Apr2022, Vol. 145 Issue 4, p484-485. 2p.
Subjects: Neurocysticercosis, Epilepsy, Carbamazepine, Levetiracetam
Abstract: The authors have mentioned most adverse effects of CBZ were minor, but 3 patients had to discontinue the medication due to rash, making the adverse effects severe in grading. Keywords: antiepileptic drugs; antiseizure medications; epilepsy; neurocysticercosis EN antiepileptic drugs antiseizure medications epilepsy neurocysticercosis 484 485 2 03/11/22 20220401 NES 220401 We read with interest the recent article titled "Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis" by Santhosh et al.1 The authors have concluded that carbamazepine (CBZ) and levetiracetam (LEV) could be used as alternatives in newly diagnosed patients of neurocysticercosis (NCC) at the behest of minor side effects in the CBZ group. [Extracted from the article]
Copyright of Acta Neurologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 155659438
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Panda%2C+Prateek+Kumar%22">Panda, Prateek Kumar</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sharawat%2C+Indar+Kumar%22">Sharawat, Indar Kumar</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Acta+Neurologica+Scandinavica%22">Acta Neurologica Scandinavica</searchLink>. Apr2022, Vol. 145 Issue 4, p484-485. 2p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Neurocysticercosis%22">Neurocysticercosis</searchLink><br /><searchLink fieldCode="DE" term="%22Epilepsy%22">Epilepsy</searchLink><br /><searchLink fieldCode="DE" term="%22Carbamazepine%22">Carbamazepine</searchLink><br /><searchLink fieldCode="DE" term="%22Levetiracetam%22">Levetiracetam</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The authors have mentioned most adverse effects of CBZ were minor, but 3 patients had to discontinue the medication due to rash, making the adverse effects severe in grading. Keywords: antiepileptic drugs; antiseizure medications; epilepsy; neurocysticercosis EN antiepileptic drugs antiseizure medications epilepsy neurocysticercosis 484 485 2 03/11/22 20220401 NES 220401 We read with interest the recent article titled "Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis" by Santhosh et al.1 The authors have concluded that carbamazepine (CBZ) and levetiracetam (LEV) could be used as alternatives in newly diagnosed patients of neurocysticercosis (NCC) at the behest of minor side effects in the CBZ group. [Extracted from the article]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Acta Neurologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=155659438
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ane.13424
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: 484
    Subjects:
      – SubjectFull: Neurocysticercosis
        Type: general
      – SubjectFull: Epilepsy
        Type: general
      – SubjectFull: Carbamazepine
        Type: general
      – SubjectFull: Levetiracetam
        Type: general
    Titles:
      – TitleFull: Carbamazepine or levetiracetam: Which one is better in neurocysticercosis?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Panda, Prateek Kumar
      – PersonEntity:
          Name:
            NameFull: Sharawat, Indar Kumar
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: Apr2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 00016314
          Numbering:
            – Type: volume
              Value: 145
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Acta Neurologica Scandinavica
              Type: main
ResultId 1